{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T05:33:17Z","timestamp":1794807197841,"version":"4.9.1"},"reference-count":61,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100022425","name":"Institut Du Cancer de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000027","name":"Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.xcrm.2023.101188","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T13:47:32Z","timestamp":1695131252000},"page":"101188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma"],"prefix":"10.1016","volume":"4","author":[{"given":"Bertrand","family":"Allard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Jacoberger-Foissac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Cousineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yacine","family":"Bareche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Buisseret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel","family":"Chrobak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Allard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Pommey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Ah-Pine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastien","family":"Duquenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7833-4228","authenticated-orcid":false,"given":"John","family":"Stagg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2023.101188_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41571-020-0382-2","article-title":"The adenosine pathway in immuno-oncology","volume":"17","author":"Allard","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2023.101188_bib2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1038\/sj.cdd.4402132","article-title":"Adenosine, an endogenous distress signal, modulates tissue damage and repair","volume":"14","author":"Fredholm","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2023.101188_bib3","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/414916a","article-title":"Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage","volume":"414","author":"Ohta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101188_bib4","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0605251103","article-title":"A2A adenosine receptor protects tumors from antitumor T\u00a0cells","volume":"103","author":"Ohta","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101188_bib5","doi-asserted-by":"crossref","first-page":"14711","DOI":"10.1073\/pnas.1308209110","article-title":"Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors","volume":"110","author":"Beavis","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101188_bib6","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1158\/0008-5472.CAN-17-2826","article-title":"A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment","volume":"78","author":"Young","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101188_bib7","doi-asserted-by":"crossref","first-page":"7250","DOI":"10.1158\/0008-5472.CAN-13-3583","article-title":"Myeloid Expression of Adenosine A2A Receptor Suppresses T and NK Cell Responses in the Solid Tumor Microenvironment","volume":"74","author":"Cekic","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101188_bib8","doi-asserted-by":"crossref","first-page":"277ra30","DOI":"10.1126\/scitranslmed.aaa1260","article-title":"Immunological mechanisms of the antitumor effects of supplemental oxygenation","volume":"7","author":"Hatfield","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2023.101188_bib9","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1158\/2326-6066.CIR-14-0211","article-title":"Adenosine Receptor 2A Blockade Increases the Efficacy of Anti\u2013PD-1 through Enhanced Antitumor T-cell Responses","volume":"3","author":"Beavis","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2023.101188_bib10","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1172\/JCI89455","article-title":"Targeting the adenosine 2A receptor enhances chimeric antigen receptor T\u00a0cell efficacy","volume":"127","author":"Beavis","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.101188_bib11","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1158\/0008-5472.CAN-14-0957","article-title":"Antimetastatic Effects of Blocking PD-1 and the Adenosine A2A Receptor","volume":"74","author":"Mittal","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101188_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ccell.2016.06.025","article-title":"Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses","volume":"30","author":"Young","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101188_bib13","doi-asserted-by":"crossref","first-page":"11091","DOI":"10.1073\/pnas.1222251110","article-title":"CD73 promotes anthracycline resistance and poor prognosis in triple negative breast cancer","volume":"110","author":"Loi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101188_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00262-018-2186-0","article-title":"Inhibition of the adenosine A2a receptor modulates expression of T\u00a0cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models","volume":"67","author":"Leone","year":"2018","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2023.101188_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1158\/2326-6066.CIR-18-0056","article-title":"A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to Anti\u2013PD-(L)1 and Anti\u2013CTLA-4 in Preclinical Models","volume":"6","author":"Willingham","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2023.101188_bib16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00262-011-1155-7","article-title":"Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor","volume":"61","author":"Waickman","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.xcrm.2023.101188_bib17","doi-asserted-by":"crossref","first-page":"CT152","DOI":"10.1158\/1538-7445.AM2020-CT152","article-title":"Abstract CT152: First in human study with EOS100850, a novel potent A2A antagonist, shows excellent tolerance and clinical benefit in immune resistant advanced cancers","volume":"80","author":"Buisseret","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2023.101188_bib18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1158\/2159-8290.CD-19-0980","article-title":"Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer","volume":"10","author":"Fong","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2023.101188_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.29777","article-title":"Disruption of adenosine 2A receptor exacerbates NAFLD through increasing inflammatory responses and SREBP1c activity","volume":"68","author":"Cai","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2023.101188_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1530\/JOE-19-0198","article-title":"Mice lacking adenosine 2A receptor reveal increased severity of MCD-induced NASH","volume":"243","author":"Zhou","year":"2019","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.xcrm.2023.101188_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/CS20110504","article-title":"Adenosine A2a Receptor Stimulation Prevents Hepatocyte Lipotoxicity and Non-alcoholic Steatohepatitis (NASH) in Rats","volume":"123","author":"Imarisio","year":"2012","journal-title":"Clin. Sci. (London, England : 1979)"},{"key":"10.1016\/j.xcrm.2023.101188_bib22","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trsl.2016.11.009","article-title":"Adenosine A2a receptor stimulation blocks development of nonalcoholic steatohepatitis in mice by multilevel inhibition of signals that cause immunolipotoxicity","volume":"182","author":"Alchera","year":"2017","journal-title":"Transl. Res."},{"key":"10.1016\/j.xcrm.2023.101188_bib23","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.3390\/cells10113171","article-title":"Ischemia\/Reperfusion Injury of Fatty Liver Is Protected by A2AR and Exacerbated by A1R Stimulation through Opposite Effects on ASK1 Activation","volume":"10","author":"Alchera","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.xcrm.2023.101188_bib24","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1084\/jem.20061097","article-title":"Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation","volume":"203","author":"Lappas","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2023.101188_bib25","doi-asserted-by":"crossref","first-page":"5040","DOI":"10.4049\/jimmunol.174.8.5040","article-title":"A2A Adenosine Receptors on Bone Marrow-Derived Cells Protect Liver from Ischemia-Reperfusion Injury","volume":"174","author":"Day","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2023.101188_bib26","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1007\/s00535-005-1609-9","article-title":"Selective A2A adenosine agonist ATL-146e attenuates acute lethal liver injury in mice","volume":"40","author":"Odashima","year":"2005","journal-title":"J.\u00a0Gastroenterol."},{"key":"10.1016\/j.xcrm.2023.101188_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature13816","article-title":"Adenosine activates brown adipose tissue and recruits beige adipocytes via A 2A receptors","volume":"516","author":"Gnad","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101188_bib28","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2023.101188_bib29","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.xcrm.2023.101188_bib30","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2023.101188_bib31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1002\/cncr.29936","article-title":"Annual Report to the Nation on the Status of Cancer, 1975\u20132012, Featuring the Increasing Incidence of Liver Cancer","volume":"122","author":"Ryerson","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2023.101188_bib32","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of Hepatocellular Carcinoma in the United States: Where Are We? Where Do We Go?","volume":"60","author":"El-Serag","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2023.101188_bib33","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1038\/s41467-021-23331-5","article-title":"CRISPR\/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T\u00a0cell efficacy","volume":"12","author":"Giuffrida","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101188_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-019-0724-7","article-title":"CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K\/AKT signaling by inducing Rap1-mediated membrane localization of P110\u03b2 and predicts poor prognosis","volume":"12","author":"Ma","year":"2019","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2023.101188_bib35","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s13045-021-01207-x","article-title":"Amplification of spatially isolated adenosine pathway by tumor\u2013macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma","volume":"14","author":"Lu","year":"2021","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2023.101188_bib36","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2010.05.007","article-title":"CD39\/ENTPD1 expression by CD4+Foxp3+ regulatory T\u00a0cells promotes hepatic metastatic tumor growth in mice","volume":"139","author":"Sun","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2023.101188_bib37","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12072-019-10003-2","article-title":"Targeting adenosinergic pathway enhances the anti-tumor efficacy of sorafenib in hepatocellular carcinoma","volume":"14","author":"Liao","year":"2020","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.xcrm.2023.101188_bib38","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101188_bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/hep.25989","article-title":"Disordered purinergic signaling and abnormal cellular metabolism are associated with development of liver cancer in Cd39\/ENTPD1 null mice","volume":"57","author":"Sun","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2023.101188_bib40","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1354\/vp.08-VP-0201-R-AM","article-title":"Ectonucleoside Triphosphate Diphosphohydrolase Type 5 (Entpd5)-Deficient Mice Develop Progressive Hepatopathy, Hepatocellular Tumors, and Spermatogenic Arrest","volume":"46","author":"Read","year":"2009","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.xcrm.2023.101188_bib41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jcmgh.2021.01.016","article-title":"CD73 Maintains Hepatocyte Metabolic Integrity and Mouse Liver Homeostasis in a Sex-Dependent Manner","volume":"12","author":"Alcedo","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2023.101188_bib42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/41771","article-title":"Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A 2a receptor","volume":"388","author":"Ledent","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101188_bib43","doi-asserted-by":"crossref","first-page":"9192","DOI":"10.1523\/JNEUROSCI.19-21-09192.1999","article-title":"A2A Adenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice","volume":"19","author":"Chen","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.xcrm.2023.101188_bib44","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/ncomms15019","article-title":"Endogenous adenosine maintains cartilage homeostasis and exogenous adenosine inhibits osteoarthritis progression","volume":"8","author":"Corciulo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2023.101188_bib45","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1096\/fj.201700398R","article-title":"A2A adenosine receptors control pancreatic dysfunction in high-fat-diet-induced obesity","volume":"31","author":"Cs\u00f3ka","year":"2017","journal-title":"FASEB. J."},{"key":"10.1016\/j.xcrm.2023.101188_bib46","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1530\/JOE-18-0169","article-title":"Regulation of Adipose Tissue Inflammation by Adenosine 2A Receptor in Obese Mice","volume":"239","author":"Pei","year":"2018","journal-title":"J.\u00a0Endocrinol."},{"key":"10.1016\/j.xcrm.2023.101188_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ccr.2014.07.001","article-title":"ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development","volume":"26","author":"Nakagawa","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101188_bib48","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1096\/fj.99-0508com","article-title":"Adenosine inhibits IL-12 and TNF-\u03b1 production via adenosine A2a receptor-dependent and independent mechanisms","volume":"14","author":"Hask\u00f3","year":"2000","journal-title":"FASEB J"},{"key":"10.1016\/j.xcrm.2023.101188_bib49","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ccell.2014.09.003","article-title":"Metabolic activation of intrahepatic CD8+ T\u00a0cells and NKT cells causes nonalcoholic steatohepatitis and liver cancer via cross-talk with hepatocytes","volume":"26","author":"Wolf","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2023.101188_bib50","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1053\/j.gastro.2017.01.021","article-title":"Stearoyl-CoA Desaturase Promotes Liver Fibrosis and Tumor Development in Mice via Wnt Signaling and Stabilization of Low Density Lipoprotein Receptor-related Proteins 5 and 6","volume":"152","author":"Lai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2023.101188_bib51","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.132384699","article-title":"Loss of stearoyl\u2013CoA desaturase-1 function protects mice against adiposity","volume":"99","author":"Ntambi","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2023.101188_bib52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nature16969","article-title":"NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis","volume":"531","author":"Ma","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101188_bib53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/j.gastro.2020.09.031","article-title":"Steatohepatitis Impairs T-cell-Directed Immunotherapies Against Liver Tumors in Mice","volume":"160","author":"Heinrich","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2023.101188_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jim.2014.05.009","article-title":"Comparative analysis of the efficiency and specificity of myeloid-Cre deleting strains using ROSA-EYFP reporter mice","volume":"408","author":"Abram","year":"2014","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.xcrm.2023.101188_bib55","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/sj.npp.1300630","article-title":"A Crucial Role for Forebrain Adenosine A2A Receptors in Amphetamine Sensitization","volume":"30","author":"Bastia","year":"2005","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.xcrm.2023.101188_bib57","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1172\/JCI91786","article-title":"HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis","volume":"128","author":"Hernandez","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2023.101188_bib59","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2023.101188_bib60","volume":"514","author":"Xue","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101188_bib61","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ng.343","volume":"41","author":"Mates","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2023.101188_bib56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2023.101188_bib58","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.1182\/blood-2010-07-295949","article-title":"Antibody targeting KIT as pretransplantation conditioning in immunocompetent mice","volume":"116","author":"Xue","year":"2010","journal-title":"Blood"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123003555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379123003555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:56:39Z","timestamp":1762988199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379123003555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2666379123003555"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101188","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenosine A2A receptor is a tumor suppressor of NASH-associated hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2023.101188","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"101188"}}